Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP288-AWP288, February 1, 2024. Background:Cerebrovascular diseases (CVD) represent a Global Health concern, being the first cause of disability worldwide and second cause of mortality (first in Brazil). Mortality percentages were: SAH=20.2%, ICH=25.3%, Ischemic Stroke=15.3%. were Female.

Cerebrovascular Disease 40

Cerebrovascular Disease Thrombolysis Public Health Hemorrhage 40

Stroke Journal

JANUARY 18, 2024

Stroke, Ahead of Print. Accumulating evidence supports a link between sleep disorders, disturbed sleep, and adverse brain health, ranging from stroke to subclinical cerebrovascular disease to cognitive outcomes, including the development of Alzheimer disease and Alzheimer disease–related dementias.

Dementia 90

Dementia Cerebrovascular Disease Biomarkers Stroke 90

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP270-ATP270, February 1, 2025. Introduction:Syphilis is associated with increased risk of cerebrovascular disease and acute stroke; stroke may even be the initial clinical manifestation of syphilis (Images 1 and 2).

Stroke 40

Stroke Strokes Hospital Laboratory 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP345-AWP345, February 1, 2025. Introduction:Ischemic stroke is an acute metabolic and cerebrovascular disease that leads to high mortality and disability rate in the world. Genetic deletion of Sdc4 significantly prevents brain injury in mice at 24 hours following MCAO.

Stroke 40

Stroke Strokes Cerebrovascular Disease Outcomes 40

Stroke Journal

DECEMBER 11, 2024

Stroke, Ahead of Print. Antibodies directed at the amyloid- peptide offer the prospect of disease-modifying therapy for early-stage Alzheimer disease but also carry the risk of brain edema or bleeding events, collectively designated amyloid-related imaging abnormalities.

Cerebrovascular Disease 40

Cerebrovascular Disease Thrombolysis Stroke Strokes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ADP15-ADP15, February 1, 2025. Background:White matter hyperintensities (WMH) of presumed vascular origin can be associated with vascular cognitive impairment and dementia. However, WMH are also seen in asymptomatic subjects.

Cerebrovascular Disease 40

Cerebrovascular Disease Dementia Risk Factors Cardiovascular Disease 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page A139-A139, February 1, 2025. We divided this population into 3 groups: (a) those with a diagnosis of CAA, (b) those with other cerebrovascular disease without CAA, and (c) those without CAA or other cerebrovascular disease. and prevalent cerebrovascular disease (HR, 1.4;

Hemorrhage 40

Hemorrhage Cerebrovascular Disease Dementia Document 40

Journal of Cardiovascular Pharmacology

AUGUST 1, 2024

Thrombosis continues to pose a significant challenge in cardiovascular and cerebrovascular diseases, contributing to severe health complications such as myocardial infarction, acute ischemic stroke, and venous thromboembolism. In this paper, we comment the findings reported by Liu et al.

Cerebrovascular Disease 40

Cerebrovascular Disease Myocardial Infarction Thrombosis Stroke 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP229-AWP229, February 1, 2025. Introduction:Cerebral amyloid angiopathy (CAA) is a significant cause of cerebrovascular disease and cognitive decline in elderly patients. CAA and ischemic and hemorrhagic stroke were identified using previously validated ICD-10 codes. 95% CI, 19.6-52.4),

Hemorrhage 40

Hemorrhage Medicare Stroke Strokes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP158-AWP158, February 1, 2025. Objective:Socioeconomic disparities significantly affect the treatment and outcomes of cardiovascular and cerebrovascular diseases, including acute ischemic stroke. SES was not a significant predictor of good functional outcomes (mRS 0-2).Conclusion:This

Outcomes 40

Outcomes Stroke Strokes Hospital 40

Frontiers in Cardiovascular Medicine

JANUARY 14, 2024

Results CV event rates among patients treated with statins who have established CV disease, including coronary artery disease, cerebrovascular disease, or peripheral arterial disease, accumulate over time, with a cumulative incidence of CV events reaching up to approximately 40% over 10 years.

Peripheral Arterial Disease 64

Peripheral Arterial Disease Cardiovascular Disease Coronary Artery Disease Cerebrovascular Disease 64

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP74-ATMP74, February 1, 2025. Background:Ischemic stroke is the most common cerebrovascular disease worldwide and the leading cause of permanent disability, which imposes a heavy burden on society and families.

Stroke 40

Stroke Strokes Cerebrovascular Disease 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP280-ATP280, February 1, 2024. As access and coverage of genetic testing has increased, it is being used more commonly in adults with strokes. Indications for testing included evaluation of carotid and vertebral dissections, recurrent stroke, cryptogenic stroke, and leukoencephalopathy.

Stroke 40

Stroke Strokes Cerebrovascular Disease Outpatient 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATMP102-ATMP102, February 1, 2024. Introduction:Lipoprotein(a) [Lp(a)] is a known risk factor for cardiovascular disease; however, its association with cerebrovascular disease is not as well established.Methods:Data from HCHS/SOL, a population-based cohort of Hispanics/Latinos, was utilized.

Cerebrovascular Disease 40

Cerebrovascular Disease Stroke Strokes Risk Factors 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ADP1-ADP1, February 1, 2025. Background:Cerebral amyloid angiopathy (CAA) is a hemorrhagic cerebrovascular disease that is thought to be due to excess protein deposition in vessel walls that lead to fragility and increase the risk of rupture.

Thrombolysis 40

Thrombolysis Stroke Strokes Cerebrovascular Disease 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP88-ATMP88, February 1, 2025. Introduction:Pediatric and young adult cerebrovascular disease is more commonly associated with genetic conditions compared to in adults. Individuals with perinatal or isolated arterial ischemic stroke were not included.

Pediatrics 40

Pediatrics Hemorrhage Stroke Strokes 40

Stroke Journal

OCTOBER 10, 2023

Stroke, Volume 54, Issue 12 , Page 3054-3063, December 1, 2023. BACKGROUND:Patients with end-stage kidney disease undergoing dialysis are at significant risk of stroke. Whether dialysis modality is associated with cerebrovascular disease is unclear. The primary outcome was incident acute ischemic stroke.

Kidney Disease 40

Kidney Disease Stroke Strokes Cerebrovascular Disease 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP271-ATP271, February 1, 2024. Introduction:Despite significant efforts to increase public awareness of cerebrovascular disease, the incidence of stroke and transient ischemic attack (TIA) in young adults has remained elevated, representing a major public health concern.

Stroke 40

Stroke Strokes Cerebrovascular Disease Risk Factors 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP291-ATP291, February 1, 2024. Since endothelial dysfunction is implicated in stroke pathogenesis and is featured with suppressed endothelial nitric oxide (NO) synthase (eNOS) and NO deficiency, restoring endothelial NO represents a promising approach to treating stroke injury.

Stroke 40

Stroke Strokes Cerebrovascular Disease Innovation 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP207-AWP207, February 1, 2025. Background:Machine learning (ML) approaches can solve predictive problems in stroke care but often require large, labeled datasets. In Tier 3, we used validated stroke diagnosis codes at discharge. Tier 1 achieved 91.9% accuracy, 89.4% sensitivity, 93.2%

Cerebrovascular Disease 40

Cerebrovascular Disease Stroke Strokes Outcomes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP110-ATP110, February 1, 2025. Introduction:Cardiovascular comorbidities are highly prevalent in patients who suffer from cerebrovascular disease. Dyslipidemia also contributes significantly to cardiovascular disease risk.

Exercise 40

Exercise Stroke Strokes Cerebrovascular Disease 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP66-AWP66, February 1, 2024. Background:With the advent of endovascular therapy as a treatment modality for LVO stroke, the importance of stroke networks has become increasingly clear. ICD10 Codes I60-I69 were used to indicate cerebrovascular disease.

Cerebrovascular Disease 40

Cerebrovascular Disease Hospital Stroke Strokes 40

Stroke: Vascular and Interventional Neurology

AUGUST 26, 2024

Stroke: Vascular and Interventional Neurology, Ahead of Print. The objective is to describe a comprehensive analysis of patients with bacterial meningitis exacerbate by cerebrovascular complications. We reviewed the literature on cerebrovascular complications in adult patients with bacterial meningitis.

Cerebrovascular Disease 40

Cerebrovascular Disease Thrombosis Hemorrhage Outcomes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionStroke is the most common manifestation of cerebrovascular disease, which requires prompt diagnosis and treatment. To reduce the rising death and disability due to stroke in Africa, adequate vascular neurology services are crucial.

Cerebrovascular Disease 40

Cerebrovascular Disease Dementia Stroke Strokes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP394-AWP394, February 1, 2025. Additionally, mass spectrometry was employed to measure tHcy levels in both plasma and cerebrospinal fluid (CSF) samples collected from 56 patients with cerebrovascular disease. The viability of the cells was evaluated using MTT method.

Cerebrovascular Disease 40

Cerebrovascular Disease Stroke Strokes Circulation 40

Frontiers in Cardiovascular Medicine

JANUARY 21, 2024

Background and aims Epidemiology of atherosclerotic cardiovascular disease might be different in patients with polygenic hypercholesterolemia plus high levels (≥30 mg/dl) of Lp(a) (H-Lpa) than in those with polygenic hypercholesterolemia alone (H-LDL). 3.17, P  = 0.006). Occurrence of acute CAD was higher in H-Lpa men (HR 3.1,

Cardiovascular Disease 45

Cardiovascular Disease Peripheral Arterial Disease Coronary Artery Disease Cerebrovascular Disease 45

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP222-AWP222, February 1, 2024. Introduction:Moyamoya is a progressive cerebrovascular disease characterized by stenosis of the cerebral arteries in the anterior circulation and less often the posterior circulation. In our cohort 7.2%

Stenosis 40

Stenosis Sickle Cell Disease Cerebrovascular Disease Pediatrics 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page A78-A78, February 1, 2025. Introduction:Intracranial aneurysm (IA), a cerebrovascular disease affecting 3-5% of US population, leads to subarachnoid hemorrage.

Aneurysm 40

Aneurysm Cerebrovascular Disease Circulation Stroke 40

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP93-ATMP93, February 1, 2025. Conclusion:We report a large cohort of MAGIC usage in the treatment of pediatric cerebrovascular disease over approximately 3 decades. These catheters have been FDA-approved for adults, but no catheter has been indicated for pediatric use.

Pediatrics 40

Pediatrics Embolism Cerebrovascular Disease Stroke 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWMP118-AWMP118, February 1, 2024. Introduction:Moyamoya disease (MMD) is a rare cerebrovascular disease that can lead to stroke.

Cerebrovascular Disease 40

Cerebrovascular Disease Stroke Strokes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP346-ATP346, February 1, 2025. Objectives:Moyamoya Disease (MMD) is a complex cerebrovascular disease marked by progressive narrowing in the cerebral arteries.

Cerebrovascular Disease 40

Cerebrovascular Disease Stroke Strokes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP11-ATMP11, February 1, 2025. Introduction:Moyamoya disease (MMD) is a rare cerebrovascular disease causing nonatherosclerotic intracranial arterial stenosis in children and young adults. However, this variant is rarely found in patients of other ethnicity.

Stenosis 40

Stenosis Cerebrovascular Disease Hemorrhage Stroke 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP284-ATP284, February 1, 2024. Objectives:Moyamoya Disease (MMD) is a progressive occlusive cerebrovascular disease with unknown etiology and pathogenesis.

Cerebrovascular Disease 40

Cerebrovascular Disease Aneurysm Circulation Stroke 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page A18-A18, February 1, 2024. In patients with preexisting cerebrovascular disease, pollution exposure can compound underlying pathology and may accelerate functional decline. Background:Exposure to ambient air pollution causes neuroinflammation and white matter (WM) damage.

Cerebrovascular Disease 40

Cerebrovascular Disease Stenosis Stroke Strokes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. The patient was diagnosed with ACA territory stroke complicated by PH2‐type hemorrhagic conversion. She improved clinically and was discharged to rehab with a diagnosis of recurrent hemorrhage attributed to anticoagulant use and recent stroke.

Hemorrhage 40

Hemorrhage AFIB Cerebrovascular Disease Thrombosis 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. He was started on secondary stroke prevention and referred to vascular surgery for evaluation of revascularization. Duplex US revealed 80‐99% stenosis of both right and left proximal internal carotid arteries.

Stenosis 40

Stenosis Cerebrovascular Disease Diabetes Stroke 40